Chronic Kidney Disease in Brazil: Current Status and Recommended Improvements

被引:0
作者
Bauer, Andrea Carla [1 ]
Elias, Rosilene M. [2 ,3 ]
Abensur, Hugo [2 ,4 ]
Batista, Marcelo Costa [5 ,6 ]
Jansen, Angela Marie [7 ]
Riella, Miguel Carlos [8 ]
机构
[1] Univ Fed Rio Grande Sul UFRGS, Hosp Clin Porto Alegre HCPA, Dept Internal Med, Nephrol Div, Porto Alegre, Brazil
[2] Univ Sao Paulo, Hosp Clin HCFMUSP, Nephrol Div, Sao Paulo, Brazil
[3] Univ Nove Julho UNINOVE, Nephrol Div, Sao Paulo, Brazil
[4] BP Beneficencia Portuguesa, Nephrol Div, Sao Paulo, Brazil
[5] Univ Fed Sao Paulo, Nephrol Div, Sao Paulo, Brazil
[6] Hosp Israelita Albert Einstein, Sao Paulo, Brazil
[7] Amer Hlth Fdn, Washington, DC 20036 USA
[8] Hosp Univ Evangel Mackenzie, Dept Med, Nephrol Div, Curitiba, Brazil
关键词
Chronic kidney disease screening; Early diagnosis of chronic kidney disease; Albuminuria; Estimated glomerular filtration rate; Healthcare; GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; CARDIOVASCULAR OUTCOMES; RISK; POPULATION; PREVALENCE; HEALTH; METAANALYSIS; ASSOCIATION; APOL1;
D O I
10.1159/000538068
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Over the last 3 decades, over 700 million individuals worldwide have been diagnosed with chronic kidney disease (CKD). In a 2017 survey in southern Brazil, 11.4% of those surveyed had CKD. Early identification and effective therapy in Brazil may reduce CKD's impact. This panel discusses the early diagnosis and treatment of CKD and the barriers and actions needed to improve the management of CKD in Brazil. A panel of Brazilian nephrologists was provided with relevant questions to address before a multiday conference. During this meeting, each narrative was discussed and edited through several rounds until agreement on the relevant topics and recommendations was achieved. Summary: Panelists highlighted hurdles to early diagnosis and treatment of CKD. These include, but are not limited to, a lack of public and patient education, updated recommendations, multidisciplinary CKD treatment, and a national CKD database. People-centered, physician-centered, and healthcare institution-centered actions can be taken to improve outcomes. Patient empowerment is needed via multiple channels of CKD education and access to health-monitoring wearables and apps. Primary care clinicians and nonspecialists must be trained to screen and manage CKD-causing illnesses, including diabetes and hypertension. The healthcare system may implement a national health data gathering system, more screening tests, automated test result reporting, and telehealth. Key Messages: Increasing access to early diagnosis can provide a path to improving care for patients with CKD. Concerted efforts from all stakeholders are needed to overcome the barriers.
引用
收藏
页码:213 / 223
页数:11
相关论文
共 50 条
  • [21] Obesity, Anthropometric Measures and Chronic Kidney Disease Complications
    Navaneethan, Sankar D.
    Kirwan, John P.
    Arrigain, Susana
    Schreiber, Martin J.
    Sarnak, Mark J.
    Schold, Jesse D.
    AMERICAN JOURNAL OF NEPHROLOGY, 2012, 36 (03) : 219 - 227
  • [22] Chronic kidney disease in Tasmania
    Jose, Matthew D.
    Otahal, Petr
    Kirkland, Geoff
    Blizzard, Leigh
    NEPHROLOGY, 2009, 14 (08) : 743 - 749
  • [23] Diagnosing chronic kidney disease
    Glassock, Richard J.
    Winearls, Christopher
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2010, 19 (02) : 123 - 128
  • [24] Consequences of chronic kidney disease in chronic obstructive pulmonary disease
    Trudzinski, Franziska C.
    Alqudrah, Mohamad
    Omlor, Albert
    Zewinger, Stephen
    Fliser, Danilo
    Speer, Timotheus
    Seiler, Frederik
    Biertz, Frank
    Koch, Armin
    Vogelmeier, Claus
    Welte, Tobias
    Watz, Henrik
    Waschki, Benjamin
    Faehndrich, Sebastian
    Joerres, Rudolf
    Bals, Robert
    RESPIRATORY RESEARCH, 2019, 20 (1):
  • [25] Low statin use in nondialysis-dependent chronic kidney disease in the absence of clinical atherosclerotic cardiovascular disease or diabetes
    Markossian, Talar W.
    Kramer, Holly J.
    Burge, Nicholas J.
    Pacold, Ivan V.
    Leehey, David J.
    Huo, Zhiping
    Schneider, Julia
    Ling, Benjamin
    Stroupe, Kevin T.
    CLINICAL KIDNEY JOURNAL, 2019, 12 (04) : 530 - 537
  • [26] HBV infection is a risk factor for chronic kidney disease: Systematic review and meta-analysis
    Fabrizi, F.
    Cerutti, R.
    Donato, F. M.
    Messa, P.
    REVISTA CLINICA ESPANOLA, 2021, 221 (10): : 600 - 611
  • [27] Development and validation of a chronic kidney disease progression model using patient-level simulations
    Ramos, Mafalda
    Gerlier, Laetitia
    Uster, Anastasia
    Muttram, Louise
    Steubl, Dominik
    Frankel, Andrew H.
    Lamotte, Mark
    RENAL FAILURE, 2024, 46 (02)
  • [28] Laboratory investigation and follow-up of chronic kidney disease stage 3 in primary care
    Aakre, Kristin M.
    Thue, Geir
    Svarstad, Einar
    Skadberg, Oyvind
    Sandberg, Sverre
    CLINICA CHIMICA ACTA, 2011, 412 (11-12) : 1138 - 1142
  • [29] Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased
    Moynihan, Ray
    Glassock, Richard
    Doust, Jenny
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [30] Renal biomarkers in cats: A review of the current status in chronic kidney disease
    Kongtasai, Thirawut
    Paepe, Dominique
    Meyer, Evelyne
    Mortier, Femke
    Marynissen, Sofie
    Stammeleer, Lisa
    Defauw, Pieter
    Daminet, Sylvie
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2022, 36 (02) : 379 - 396